Axitinib, a small molecule tyrosine kinase inhibitor (TKI), is making waves in the world of cancer treatment. It's not your typical chemotherapy drug, but a targeted therapy that takes aim at specific molecular pathways involved in tumor growth and survival. This article delves into the fascinating world of Axitinib API, exploring its mechanism of action, clinical applications, and potential...